Barely Significant
← all excerpts

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab.

J Clin Med · 2020 · PMC7760916 · PMID 33261056

Europe PMCDOI
1
hedged sentence
0.3127
closest p · 6.3× alpha
0.3127
boldest claim

The sentences

did not reach statistical significancep = 0.3127not close (p > 0.1)
Conversely, in the 24 patients whose relative ctDNA abundance was below or equal to the median (7 patients treated with chemotherapy, 17 patients treated with atezolizumab), patients treated with atezolizumab had a longer OS than in the chemotherapy arm in univariate analysis, although the difference did not reach statistical significance (HR atezolizumab arm = 0.55 (95% CI: 0.17–1.75) p = 0.3127; Figure 3 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.